Get the Stockscreener App
3.57
1.13%
0.04
After Hours:
3.50
-0.07
-1.96%
Compass Therapeutics Inc stock is traded at $3.57, with a volume of 590.17K.
It is up +1.13% in the last 24 hours and up +12.62% over the past month.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
See More
Previous Close:
$3.53
Open:
$3.5
24h Volume:
590.17K
Relative Volume:
0.59
Market Cap:
$493.67M
Revenue:
-
Net Income/Loss:
$-45.44M
P/E Ratio:
-10.20
EPS:
-0.35
Net Cash Flow:
$-42.28M
1W Performance:
+3.78%
1M Performance:
+12.62%
6M Performance:
+42.23%
1Y Performance:
+131.82%
1-Day Range:
$3.44
$3.62
1-Week Range:
$3.37
$3.70
52-Week Range:
$1.27
$4.08
Compass Therapeutics Inc Stock (CMPX) Company Profile
Name
Compass Therapeutics Inc
Sector
Industry
Phone
617-500-8099
Address
80 GUEST STREET, BOSTON
Compare CMPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
3.57 | 603.94M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Resumed | Raymond James | Outperform |
| Apr-02-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-24-25 | Initiated | Guggenheim | Buy |
| Feb-19-25 | Initiated | Piper Sandler | Overweight |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-15-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-16-24 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-31-23 | Initiated | Jefferies | Buy |
| Jan-27-23 | Initiated | Stifel | Buy |
| May-23-22 | Resumed | H.C. Wainwright | Buy |
| Mar-15-22 | Initiated | Ladenburg Thalmann | Buy |
| Jan-19-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Raymond James | Outperform |
| Dec-20-21 | Initiated | SVB Leerink | Outperform |
| Dec-15-21 | Initiated | Wedbush | Outperform |
View All
Compass Therapeutics Inc Stock (CMPX) Latest News
American Century Companies Inc. Makes New Investment in Compass Therapeutics, Inc. $CMPX - MarketBeat
Compass Therapeutics, Inc. $CMPX Position Decreased by Adage Capital Partners GP L.L.C. - MarketBeat
Guggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer Pipeline - uk.finance.yahoo.com
Compass Therapeutics to Participate in Upcoming September Investor Events - Investing News Network
How hedge fund analytics apply to Compass Therapeutics Inc. stock2025 Key Highlights & Safe Entry Zone Tips - Newser
What’s the recovery path for long term holders of Compass Therapeutics Inc.Portfolio Performance Summary & Risk Controlled Swing Alerts - Newser
304,504 Shares in Compass Therapeutics, Inc. $CMPX Bought by Nuveen LLC - MarketBeat
Compass Therapeutics Inc. Tests 50 Day MA After Sharp DeclineJuly 2025 Weekly Recap & Stepwise Entry and Exit Trade Signals - beatles.ru
Does Compass Therapeutics Inc. offer margin of safetyTrade Entry Report & Real-Time Sentiment Analysis - 뉴스영
Baker BROS. Advisors LP Sells 1,010,132 Shares of Compass Therapeutics, Inc. $CMPX - MarketBeat
Piper Sandler Reaffirms Optimism on Compass Therapeutics (CMPX) Amid Trial Update - MSN
Relative strength of Compass Therapeutics Inc. in sector analysisTrade Risk Report & Verified Technical Signals - Newser
Visual analytics tools that track Compass Therapeutics Inc. performance2025 Technical Patterns & Weekly Momentum Picks - Newser
What MACD and RSI say about Compass Therapeutics Inc.July 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser
Will earnings trigger a reversal in Compass Therapeutics Inc.Earnings Risk Summary & Weekly Setup with High ROI Potential - Newser
VIX Spike: Is Compass Therapeutics Inc. stock risky to hold nowPortfolio Value Report & AI Forecast for Swing Trade Picks - خودرو بانک
Trend analysis for Compass Therapeutics Inc. this weekWeekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Can Compass Therapeutics Inc. navigate macro headwindsJuly 2025 Action & Fast Entry High Yield Tips - خودرو بانک
Wellington Management Group LLP Purchases New Holdings in Compass Therapeutics, Inc. $CMPX - MarketBeat
Can Compass Therapeutics Inc. lead its sector in growthWeekly Stock Report & Growth Focused Entry Reports - خودرو بانک
Sector ETF performance correlation with Compass Therapeutics Inc.Quarterly Profit Report & Capital Efficiency Focused Strategies - Newser
Will Compass Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Real-Time Market Trend Scan - Newser
Signal Recap: Can Compass Therapeutics Inc. deliver alphaMarket Risk Summary & Breakout Confirmation Trade Signals - خودرو بانک
Is Compass Therapeutics Inc. forming a breakout patternMarket Sentiment Summary & Precise Buy Zone Tips - خودرو بانک
Does Compass Therapeutics Inc. have strong fundamentals2025 Technical Patterns & Smart Money Movement Tracker - خودرو بانک
Propel Bio Management LLC Makes New $434,000 Investment in Compass Therapeutics, Inc. $CMPX - MarketBeat
Will Compass Therapeutics Inc. outperform during market ralliesTrade Volume Report & Free Verified High Yield Trade Plans - خودرو بانک
How sentiment analysis helps forecast Compass Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Stock Tips - Newser
What are analysts’ price targets for Compass Therapeutics Inc.July 2025 Recap & AI Driven Price Predictions - خودرو بانک
Intraday pattern recognizer results for Compass Therapeutics Inc.2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
Using Bollinger Bands to evaluate Compass Therapeutics Inc.2025 Price Targets & Low Drawdown Investment Strategies - Newser
Is Compass Therapeutics Inc. stock bottoming out2025 Macro Impact & Daily Entry Point Trade Alerts - Newser
Analysts Set Compass Therapeutics, Inc. (NASDAQ:CMPX) PT at $12.89 - MarketBeat
Will Compass Therapeutics Inc. stock go up soonJuly 2025 Patterns & Expert Curated Trade Setups - Newser
Technical analysis overview for Compass Therapeutics Inc. stockWeekly Investment Recap & Entry Point Confirmation Alerts - Newser
Is Compass Therapeutics Inc. backed by strong institutional buying2025 Geopolitical Influence & Reliable Price Action Trade Plans - خودرو بانک
Using Ichimoku Cloud for Compass Therapeutics Inc. technicalsPortfolio Value Report & Risk Controlled Daily Trade Plans - Newser
Multi asset correlation models including Compass Therapeutics Inc.2025 Trade Ideas & Accurate Buy Signal Notifications - Newser
Aug PreEarnings: Will Compass Therapeutics Inc. benefit from AI trends2025 EndofYear Setup & Short-Term Trading Alerts - خودرو بانک
Custom strategy builders for tracking Compass Therapeutics Inc.Portfolio Risk Summary & Verified Entry Point Signals - Newser
Is Compass Therapeutics Inc. a strong growth stockMarket Growth Summary & Free Accurate Trade Setup Notifications - خودرو بانک
Has Compass Therapeutics Inc. found a price floor2025 Bull vs Bear & Smart Money Movement Alerts - Newser
Can Compass Therapeutics Inc. hit a new high this monthWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - Newser
How to escape a deep drawdown in Compass Therapeutics Inc.2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser
What’s the MACD signal for Compass Therapeutics Inc.July 2025 Spike Watch & Reliable Breakout Forecasts - خودرو بانک
Will Compass Therapeutics Inc. price bounce be sustainableJuly 2025 Opening Moves & Technical Pattern Alert System - Newser
Can trapped investors hope for a rebound in Compass Therapeutics Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
Compass Therapeutics Inc Stock (CMPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):